Skip to main content
. 2022 Feb 6;14(3):829. doi: 10.3390/cancers14030829

Figure 1.

Figure 1

Overall survival of patients based on tumor engraftment status. Overall survival of patients with ovarian cancer (A), cervical and vaginal cancer (B), and uterine cancer (C) in the success groups and failed groups of P1. Kaplan–Meier survival analysis was carried out, and log–rank p–values, HR, and CI are shown for each of the results. HR: hazard ratio; CI: confidence interval.